The Triological Society Research Career Development Awards provide funding to otolaryngologists for their research projects at an early faculty stage, before they have received funding from the National Institutes of Health (NIH).


The Triological Society Research Career Development Awards provide funding to otolaryngologists for their research projects at an early faculty stage, before they have received funding from the National Institutes of Health (NIH).
The Arabic brief QOD demonstrated good validity and reliability in evaluating quality of life in patients affected by olfactory dysfunction (OD).
What are the comparative outcomes of juvenile nasopharyngeal angiofibroma (JNA) resection between embolized and non-embolized cohorts, and between transarterial embolization (TAE) and direct puncture embolization (DPE)?
Prolonged or repeated exposure to an odor can temporarily decrease olfactory sensitivity.
Awake videolaryngoscopy intubation is an excellent strategy to adopt in patients with laryngeal cancer, particularly if potentially complicated intubation is expected.

Social media use within otolaryngology is increasing rapidly, mainly for professional networking but also for applications that directly impact patient care, such as patient education and study recruitment.

Intracapsular tonsillectomy is a safe and effective method for performing tonsillectomy and should be included in future clinical practice guidelines for tonsillectomy.

Hypoglossal Nerve Stimulator therapy is an effective and safe surgical option for patients with moderate to severe OSA who cannot tolerate PAP therapy.

Pierre Robin sequence (PRS) has an estimated prevalence of one in 10,000 births and is characterized by micrognathia and glossoptosis leading to upper airway compromise. As airway obstruction can be life-threatening, immediate recognition and treatment are vital.

When it comes to drug therapy most of the recent buzz has been triggered by data on tirzepatide released at the American Diabetes Association 84th Scientific Sessions, suggesting that the drug may obviate the need for continuous positive airway pressure (CPAP) in nearly half of OSA patients.